SIE 0.00% 6.8¢ scigen limited

The latest 4C indicates an increasing sales, if compared with...

  1. 300 Posts.
    lightbulb Created with Sketch. 4
    The latest 4C indicates an increasing sales, if compared with the 4C for the sale period last year there is a substantial increase in sales , but expenses seem to increase at the same rate, this is not how it is works for pharmaceuticals - normally when a patient begins on a treatment the patient stays on the medication for a reasonable length of time . Insulin for diabetes the patient is likely to require increasing doses. Advertising or promotion investment is not required to keep the patient on treatment.

    Re -reading the announcements Bioton wan't to sell SIE no doubt the Chinese will buy SIE for it access to Insulin already selling in the Chinese market

    The only question is : What price will the minority shareholders be offered?
 
watchlist Created with Sketch. Add SIE (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.